GBS-MeDIP: A protocol for parallel identification of genetic and epigenetic variation in the same reduced fraction of genomes across individuals

STAR Protoc. 2022 Mar 3;3(1):101202. doi: 10.1016/j.xpro.2022.101202. eCollection 2022 Mar 18.

Abstract

The GBS-MeDIP protocol combines two previously described techniques, Genotype-by-Sequencing (GBS) and Methylated-DNA-Immunoprecipitation (MeDIP). Our method allows for parallel and cost-efficient interrogation of genetic and methylomic variants in the DNA of many reduced genomes, taking advantage of the barcoding of DNA samples performed in the GBS and the subsequent creation of DNA pools, then used as an input for the MeDIP. The GBS-MeDIP is particularly suitable to identify genetic and methylomic biomarkers when resources for whole genome interrogation are lacking.

Keywords: Cancer; Clinical Protocol; Genomics; High Throughput Screening; Molecular Biology; Sequencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Methylation* / genetics
  • DNA* / genetics
  • Epigenesis, Genetic
  • Genotype
  • Humans
  • Immunoprecipitation

Substances

  • DNA